Immunization Treatment Landscape
The Immunization Treatment Landscape
A discussion on the current rates of immunization amongst various age groups, and how to effectively administer vaccines to the general population.
Learn More about Clinical Roles
Latest News

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the goals and importance of his company, Stack, during the NASP Annual Meeting in Washington, DC.
Staff at Green Valley Pharmacy
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about how his employees and why their wellbeing matters. 
Coming to ASHP Midyear 2019
The American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting is approaching, and Pharmacy Times® will be on-site to provide comprehensive coverage from Las Vegas, Nevada. ASHP Midyear 2019 will take place December 8 to 12, 2019. 
FDA Approves Treatment for Sickle Cell Disease
Crizanlizumab-tmca (Adakveo, Novartis) is approved to reduce the frequency of vaso-occlusive crises in patients aged 16 years and older with sickle cell disease.
 
Making Sense of the New ACIP Recommendations
Previously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.
Top news of the day from across the health care landscape.
Cefiderocol (Fetroja, Shionogi) is indicated for adults with complicated urinary tract infections, including kidney infections caused by Gram-negative pathogens, who have limited or no alternative treatment options.
 
Cenobamate is an investigational antiepileptic drug that has shown broad spectrum anticonvulsant activity in preclinical studies and seizure models.
The FDA granted accelerated approval to zanubrutinib (Brukinsa, BeiGene) for the treatment of mantle cell lymphoma in adults who have received at least 1 prior therapy.
 
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how vertical integration might affect biosimilar availability in specialty pharmacy during the NASP Annual Meeting in Washington, DC.
+ Load More

Explore More About Pharmacy Times